COVID-19 and sepsis: clinical parallels of clinical course and treatment options

Authors

  • I.A. Kuchynska Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; Universal Clinic “Oberig”, Kyiv, Ukraine
  • V.M. Bogomaz Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine; Universal Clinic “Oberig”, Kyiv, Ukraine
  • O.A. Halushko Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
  • A.O. Sydorova Universal Clinic “Oberig”, Kyiv, Ukraine; Bogomolets National Medical University, Kyiv, Ukraine
  • A.H. Andriukhov Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine
  • V.P. Romanyuk Universal Clinic “Oberig”, Kyiv, Ukraine; Bogomolets National Medical University, Kyiv, Ukraine
  • L.I. Antoniuk Universal Clinic “Oberig”, Kyiv, Ukraine

DOI:

https://doi.org/10.22141/2224-0586.18.2.2022.1468

Keywords:

sepsis, systemic inflammatory response syndrome, COVID-19, immunosuppression, diagnostic criteria, treatment, review

Abstract

The article analyzes syndrome complex in sepsis and severe COVID-19, identifies the main pathophysiological priorities in the diagnosis and differences in treatment. Adaptation of existing treatment regimens for diseases with similar pathogenesis may help to improve treatment outcomes and reduce SARS-CoV-2-related mortality. However, when discussing the parallels between COVID-19 and sepsis, focusing on their similarities in immunopathogenesis and pathophysiology, the proposed treatment options should be reviewed based on the patient’s clinical assessment and laboratory parameters individually.

Downloads

Download data is not yet available.

References

Schlapbach LJ, Trück J, Roger T. Editorial: The Immunology of Sepsis-Understanding Host Susceptibility, Pathogenesis of Disease, and Avenues for Future Treatment. Front Immunol. 2020 Jun 23;11:1263. doi: 10.3389/fimmu.2020.01263.

Rudd KE, Johnson SC, Agesa KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020 Jan 18;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7.

Chang JC. Sepsis and septic shock: endothelial molecular pathogenesis associated with vascular microthrombotic disease. Thromb J. 2019 May 30;17:10. doi: 10.1186/s12959-019-0198-4.

Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013 Aug 29;369(9):840-51. doi: 10.1056/NEJMra1208623.

Pop-Began V, Păunescu V, Grigorean V, Pop-Began D, Popescu C. Molecular mechanisms in the pathogenesis of sepsis. J Med Life. 2014;7 Spec No. 2(Spec Iss 2):38-41.

Chousterman BG, Swirski FK, Weber GF. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017 Jul;39(5):517-528. doi: 10.1007/s00281-017-0639-8.

Huang M, Cai S, Su J. The Pathogenesis of Sepsis and Potential Therapeutic Targets. Int J Mol Sci. 2019 Oct 29;20(21):5376. doi: 10.3390/ijms20215376.

van der Poll T, van de Veerdonk FL, Scicluna BP, Netea MG. The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 2017 Jul;17(7):407-420. doi: 10.1038/nri.2017.36.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5.

Qin C, Zhou L, Hu Z, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020 Jul 28;71(15):762-768. doi: 10.1093/cid/ciaa248.

Wang C, Xie J, Zhao L, et al. Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients. EBioMedicine. 2020 Jul;57:102833. doi: 10.1016/j.ebiom.2020.102833.

Leisman DE, Ronner L, Pinotti R, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med. 2020 Dec;8(12):1233-1244. doi: 10.1016/S2213-2600(20)30404-5.

Remy KE, Mazer M, Striker DA, et al. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections. JCI Insight. 2020 Sep 3;5(17):e140329. doi: 10.1172/jci.insight.140329.

Wang F, Nie J, Wang H, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. J Infect Dis. 2020 May 11;221(11):1762-1769. doi: 10.1093/infdis/jiaa150.

Zheng M, Gao Y, Wang G, et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cell Mol Immunol. 2020 May;17(5):533-535. doi: 10.1038/s41423-020-0402-2.

Kostyuk TR, Levchuk AO, Sidorova AO. Study of the role of lymphopenia in the course of the COVID-19 coronavirus disease in hospitalized patients. Ukrainian Scientific Medical Youth Journal. 2021;126(3):42. (in Ukrainian).

Roham M, Abbaszadeh A, Zendehdel A, Momeni M, Mirzae N, Gholami M. Prognostic factors of sepsis rapid progression in patients admitted to Intensive Care Unit. Ann Trop Med Public Health. 2017;10:1770–3. doi: 10.4103/ATMPH.ATMPH_646_17.

Perez-Guzman PN, Daunt A, Mukherjee S, et al. Clinical Characteristics and Predictors of Outcomes of Hospitalized Patients With Coronavirus Disease 2019 in a Multiethnic London National Health Service Trust: A Retrospective Cohort Study. Clin Infect Dis. 2021 Dec 6;73(11):e4047-e4057. doi: 10.1093/cid/ciaa1091.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3.

Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19). Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5.

Grein J, Ohmagari N, Shin D, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016.

Shakoory B, Carcillo JA, Chatham WW, et al. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial. Crit Care Med. 2016 Feb;44(2):275-81. doi: 10.1097/CCM.0000000000001402.

RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436.

Kuchynska IA, Savchenko BO, Andriukhov AH, et al. Multiple-organ failure in patients with severe coronavirus disease (COVID-19). Medicina neotložnyh sostoânij. 2021;17(2):30-38. doi: 10.22141/2224-0586.17.2.2021.230632. (in Ukrainian)

Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016.

Ketcham SW, Bolig TC, Molling DJ, Sjoding MW, Flanders SA, Prescott HC. Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study. Ann Am Thorac Soc. 2021 Jun;18(6):1076-1079. doi: 10.1513/AnnalsATS.202011-1381RL.

Halushko O, Loskutov O, Kuchynska I, Synytsyn M, Boliuk M. The Main causes of the complicated course of COVID-19 in patients with diabetes mellitus and treatment (review). Georgian Med News. 2020 Oct;(307):114-120.

Published

2022-04-30

How to Cite

Kuchynska, I., Bogomaz, V., Halushko, O., Sydorova, A., Andriukhov, A., Romanyuk, V., & Antoniuk, L. (2022). COVID-19 and sepsis: clinical parallels of clinical course and treatment options. EMERGENCY MEDICINE, 18(2), 20–24. https://doi.org/10.22141/2224-0586.18.2.2022.1468

Issue

Section

Scientific Review

Most read articles by the same author(s)

1 2 3 4 > >>